The immunohistochemical expression of EGFR in ACC tumors has been characterized; in a study of 25 ACC samples, EGFR expression was quantified as weak-moderate in 32% and as strong in 64% of samples [48]. This evidence concerns the gene EGFR and adrenal cortex carcinoma.